Maryam Tabasinezhad

444 total citations
14 papers, 361 citations indexed

About

Maryam Tabasinezhad is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Maryam Tabasinezhad has authored 14 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Immunology. Recurrent topics in Maryam Tabasinezhad's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Maryam Tabasinezhad is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Maryam Tabasinezhad collaborates with scholars based in Iran, Germany and Italy. Maryam Tabasinezhad's co-authors include Nasser Samadi, Simin Sharifi, Parisa Ghanbari, Mahsa Mohseni, Mohammad‐Reza Rashidi, Mehdi Sabzichi, Fatemeh Ramezani, Hamed Hamishehkar, Bahman Yousefi and Amir Ata Saei and has published in prestigious journals such as Proteins Structure Function and Bioinformatics, Applied Biochemistry and Biotechnology and Immunology Letters.

In The Last Decade

Maryam Tabasinezhad

12 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maryam Tabasinezhad Iran 8 225 71 52 40 39 14 361
Yasemin Başbınar Türkiye 11 133 0.6× 82 1.2× 50 1.0× 19 0.5× 32 0.8× 47 367
Sawitree Chiampanichayakul Thailand 12 199 0.9× 72 1.0× 40 0.8× 41 1.0× 31 0.8× 47 409
Mingmei Liao China 11 220 1.0× 91 1.3× 49 0.9× 41 1.0× 10 0.3× 16 374
Ae Jin Choi South Korea 10 277 1.2× 49 0.7× 42 0.8× 39 1.0× 7 0.2× 21 533
Yongxiang Zheng China 11 228 1.0× 36 0.5× 48 0.9× 53 1.3× 50 1.3× 34 426
Anindita De India 11 241 1.1× 53 0.7× 38 0.7× 100 2.5× 21 0.5× 22 447
Chee-Onn Leong Malaysia 6 186 0.8× 62 0.9× 66 1.3× 60 1.5× 56 1.4× 6 381
Yuting Cao China 12 340 1.5× 73 1.0× 81 1.6× 42 1.1× 11 0.3× 40 630

Countries citing papers authored by Maryam Tabasinezhad

Since Specialization
Citations

This map shows the geographic impact of Maryam Tabasinezhad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryam Tabasinezhad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryam Tabasinezhad more than expected).

Fields of papers citing papers by Maryam Tabasinezhad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryam Tabasinezhad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryam Tabasinezhad. The network helps show where Maryam Tabasinezhad may publish in the future.

Co-authorship network of co-authors of Maryam Tabasinezhad

This figure shows the co-authorship network connecting the top 25 collaborators of Maryam Tabasinezhad. A scholar is included among the top collaborators of Maryam Tabasinezhad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryam Tabasinezhad. Maryam Tabasinezhad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Paré, Jean‐François, Maryam Tabasinezhad, Charles C.T. Hindmarch, et al.. (2023). Association of Histone H3 Trimethylation in Circulating Monocytes with Lack of Early Recurrence in Patients with Bladder Cancer following BCG Induction Therapy. Bladder Cancer. 9(2). 175–186. 2 indexed citations
2.
Barkhordari, Farzaneh, et al.. (2022). Computational analysis of fusion protein of anti-HER2 scFv and alpha luffin: A new immunotoxin protein for HER2 positive cancers. Brazilian Journal of Pharmaceutical Sciences. 58.
3.
Omidvar, Maryam, et al.. (2020). SUCLG1 mutations and mitochondrial encephalomyopathy: a case study and review of the literature. Molecular Biology Reports. 47(12). 9699–9714. 6 indexed citations
4.
Tabasinezhad, Maryam, Eskandar Omidinia, Hamzeh Rahimi, et al.. (2019). Production and Characterization of a New Variant of an Anti-Tnfα Antibody with Improved Affinity and Potency. International Journal of Drug Development and Research. 11(2).
5.
Tabasinezhad, Maryam, Yeganeh Talebkhan, Wolfgang Wenzel, et al.. (2019). Trends in therapeutic antibody affinity maturation: From in-vitro towards next-generation sequencing approaches. Immunology Letters. 212. 106–113. 46 indexed citations
6.
Tabasinezhad, Maryam, Yeganeh Talebkhan, Mir Davood Omrani, et al.. (2019). The effects of somatic mutations on EGFR interaction with anti‐EGFR monoclonal antibodies: Implication for acquired resistance. Proteins Structure Function and Bioinformatics. 88(1). 3–14. 4 indexed citations
7.
Tabasinezhad, Maryam, Fereidoun Mahboudi, Wolfgang Wenzel, et al.. (2018). The transient production of anti-TNF-α antibody Adalimumab and a comparison of its characterization to the biosimilar Cinorra. Protein Expression and Purification. 155. 59–65. 3 indexed citations
8.
Ghaedi, Hamid, Milad Bastami, Behnam Alipoor, et al.. (2016). A Bioinformatics Approach to the Identification of Variants Associated with Type 1 and Type 2 Diabetes Mellitus that Reside in Functionally Validated miRNAs Binding Sites. Biochemical Genetics. 54(3). 211–221. 13 indexed citations
9.
Ghaedi, Hamid, Maryam Tabasinezhad, Behnam Alipoor, et al.. (2016). The pre-mir-27a variant rs895819 may contribute to type 2 diabetes mellitus susceptibility in an Iranian cohort. Journal of Endocrinological Investigation. 39(10). 1187–1193. 27 indexed citations
10.
Mohseni, Mahsa, Nasser Samadi, Parisa Ghanbari, et al.. (2016). Co-treatment by docetaxel and vinblastine breaks down P-glycoprotein mediated chemo-resistance.. PubMed. 19(3). 300–9. 36 indexed citations
11.
Samadi, Nasser, Parisa Ghanbari, Mahsa Mohseni, et al.. (2014). Combination therapy increases the efficacy of docetaxel, vinblastine and tamoxifen in cancer cells. Journal of Cancer Research and Therapeutics. 10(3). 715–715. 44 indexed citations
12.
Sabzichi, Mehdi, Hamed Hamishehkar, Fatemeh Ramezani, et al.. (2014). Luteolin-loaded Phytosomes Sensitize Human Breast Carcinoma MDA-MB 231 Cells to Doxorubicin by Suppressing Nrf2 Mediated Signalling. Asian Pacific Journal of Cancer Prevention. 15(13). 5311–5316. 94 indexed citations
13.
Ghanbari, Parisa, Mahsa Mohseni, Maryam Tabasinezhad, et al.. (2014). Inhibition of Survivin Restores the Sensitivity of Breast Cancer Cells to Docetaxel and Vinblastine. Applied Biochemistry and Biotechnology. 174(2). 667–681. 45 indexed citations
14.
Samadi, Nasser, Maryam Tabasinezhad, Parisa Ghanbari, et al.. (2013). Sphingosin 1-phosphate contributes in tumor progression. Journal of Cancer Research and Therapeutics. 9(4). 556–556. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026